The ALS Association - Comment

Document ID: FDA-2010-N-0128-0038
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 21 2011, at 12:00 AM Eastern Daylight Time
Date Posted: November 4 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: September 12 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: October 24 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f58820
View Document:

This is comment on Notice

Meetings: Prescription Drug User Fee Act

View Comment

The ALS Association applauds the commitment letter released by the Agency for the reauthorization of the Prescription Drug User Fee Act (PDUFA). The proposed agreement includes provisions that would help to encourage and expedite the approval of new treatments for rare diseases like ALS, also known as Lou Gehrig’s Disease. We are pleased to submit the attached comments.

Attachments:

10-24-11 PDUFA V Comments (ALS Association)

Title:
10-24-11 PDUFA V Comments (ALS Association)

View Attachment: